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Abstract
Immunoglobulin A (IgA) mediates a key role in mucosal immunity and is a promising novel immunotherapeutic
candidate. However, difficulties in obtaining enough material often hamper in vivo explorations. We have
previously generated recombinant Chinese hamster ovary (CHO) cell lines which expressed two different HIV-1
antibodies, 3D6 and 4B3, as IgA1 [1]. One cell line (3D6-IgA) shows high production rates, whereas the other
(4B3-IgA) secretes rather low amounts of product. In order to unravel the mystery of productivity bottlenecks we
extensively characterized the cell lines regarding growth rate, IgA productivity in long-term culture,
immunofluorescence microscopy, flow cytometry and Western blotting of intra- and extracellular product (data not
shown). The generated data encouraged us to analyze whether the observed antibody productivities could be
explained by gene copy number (GCN) or mRNA levels.
Materials and methods
CHO host (ATCC CRL-9096) and recombinant cell
lines [1] were cultivated in spinner vessels (Techne, UK)
with 50 mL medium (ProCHO5, Switzerland), at 37°C
and 50 rpm.
Genomic DNA (gDNA) was isolated from 2 × 106
cells using the DNA Blood Mini Kit (Qiagen, Netherlands)
according to the manufacturers’ instructions. Quantifi-
cation was performed spectrophotometrically at an absor-
bance of 260 nm and the purity was determined by
measuring the ratio at 260 nm and 280 nm. gDNA samples
were stored at 4°C. Cellular RNA was isolated from 5 × 106
cells using the Ambion Tri Reagent Solution (Life Tech-
nologies, CA) according to the manufacturers’ instructions.
To remove DNA contaminations from extracted RNA
the preparation was digested with 3 U DNase I (Qiagen,
Netherlands) for 30 min at RT together with 160 U RNase
inhibitor (Life Technologies, CA) and then inactivated for
10 min at 75°C before another RNA precipitation step.
Purified total RNA was dissolved in 25 μl RNase free water
containing 60 U RNase inhibitor. cDNA was obtained
by reverse transcription. 1.5 μg RNA, 1 μg random primers
(Promega, WI) and 12.5 nmol dNTPs (New England
Biolabs, MA) were incubated in a reaction volume of 14 μl
for 5 min at 70°C and 2 min at room temperature. Then,
40 U RNase inhibitor, 200 U M-MLV reverse transcriptase
and buffer (both Promega, WI) were added to a reaction
volume of 20 μl and incubated for 30 min at 37°C before
denaturation for 5 min at 95°C.
Real-time PCR (qPCR) analysis was performed on a
MiniOpticon qPCR device (Biorad, CA). Primers and
the fluorogenic hydrolysis probes were synthesized by
Sigma (MO). Same primers and probes were used for
the analysis of gDNA and cDNA. The reaction mix
included iQ Supermix (Biorad, CA), 6 pmol primer and
4 pmol hydrolysis probe for HC, JC and ß-actin quanti-
fication or 12 pmol primer and 8 pmol hydrolysis probe
for LC determination in 20 μl reaction volume. 3 ng
pre-denatured (99°C, 10 min) gDNA or 3 μL cDNA
from a 1:50 dilution of the reverse transcription reaction
was used directly for qPCR. Negative controls (NC), no
template controls (NTC) and no reverse transcriptase
controls (NRT) for transcript analysis were included in
each run. The quantification cycle (Cq) was determined
by linear regression and baseline subtraction using the
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CFX Manager (Biorad, CA). The mean qPCR efficiencies
for HC, LC, JC and ß-actin were calculated from raw
fluorescence data using the LinRegPCR software appli-
cation, V12.17 [2]. Quantification was done by relative
quantification with efficiency correction [3] using
ß-actin as internal reference and expressed as ratios.
Results and discussion
qPCR was performed in six technical replicates. The Cq
values and calculated efficiencies were well reproducible
(Table 1). gDNA analysis revealed an overall higher
exogenic GCN for the low producer 4B3-IgA than for
3D6-IgA (Figure 1). On the genomic level clone 4B3-IgA
Table 1 Calculated efficiencies (E), Cq and ΔCq values and copies relative to ß-actin for gDNA and cDNA derived from
clones 3D6-IgA and 4B3-IgA
GOI Target Clone Cq max. SD [%] E SD (%) ΔCq ß-actin Copies relative to ß-actin
ß-actin gDNA 3D6-IgA 24.60 0.20 2.07 2.22 n/a n/a
4B3-IgA 24.21 0.14 2.07 2.22 n/a n/a
cDNA 3D6-IgA 18.52 0.13 2.03 0.43 n/a n/a
4B3-IgA 16.25 0.63 2.04 1.33 n/a n/a
HC gDNA 3D6-IgA 23.56 0.16 1.95 3.32 -1.03 8.28
4B3-IgA 22.11 0.14 1.95 3.32 -2.11 16.44
cDNA 3D6-IgA 21.78 0.17 1.91 1.35 3.26 0.38
4B3-IgA 19.50 0.68 1.97 1.53 3.25 0.20
JC gDNA 3D6-IgA 24.81 0.03 1.95 0.94 0.22 3.80
4B3-IgA 22.77 0.10 1.95 0.94 -1.44 11.20
cDNA 3D6-IgA 24.52 0.23 1.82 0.87 5.97 0.22
4B3-IgA 20.81 1.54 1.96 0.27 4.56 0.10
LC gDNA 3D6-IgA 24.90 0.14 2.05 0.59 0.31 0.98
4B3-IgA 21.50 0.21 2.11 1.21 -2.71 4.40
cDNA 3D6-IgA 20.26 0.20 1.88 0.75 1.73 1.30
4B3-IgA 15.02 2.36 1.98 1.30 -1.22 3.93
Figure 1 Gene copy number and transcript level of recombinant clones expressing 3D6-IgA or 4B3-IgA. The abundance of LC ( ),
JC ( ) and HC ( ) genes was calculated relative to ß-actin.
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contained two times more HC, three times more JC and
four times more LC than 3D6-IgA. Both clones incorpo-
rated more HC genes than JC than LC. This could be
due to the presence of the dhfr amplification gene on
the HC plasmid, whereas the neomycin resistance gene
was located on the JC plasmid. No selection marker
was included on the LC plasmid.
mRNA levels were additionally quantified by qPCR to
exclude any misinterpretation of our analysis due to
incompletely transfected expression cassettes, chromoso-
mal position effects or transgene silencing. Despite
higher gene copy numbers 4B3-IgA contained only half
of HC and JC transcripts as compared to 3D6-IgA. LC
was transcribed with the same range of efficiency and
resulted in three times more LC mRNA copies. In contrast
to gDNA results, LC mRNA content greatly exceeded that
of HC and JC in both clones (Figure 1). Hence, LC
content, which has been proposed to be critical for high
antibody productivities [4], should not have been limited
by mRNA. Summarized, the respective mRNA levels
differed slightly between the two recombinant cell lines,
but were presumably not sufficient for the low specific
productivity of clone 4B3-IgA.
Conclusions
An overall higher exogenic GCN was determined for the
low producer 4B3-IgA as compared to 3D6-IgA. Both
clones incorporated more HC genes than JC than LC.
Despite higher GCNs 4B3-IgA contained only half of
HC and JC mRNA transcripts as compared to 3D6-IgA.
LC was transcribed with similar efficiencies whereas LC
mRNA content greatly exceeded that of HC and JC in
both clones. All in all, differences in specific productivity,
intracellular antibody chain content and volumetric titers
of the cell lines could not sufficiently be explained
by qPCR data of GCN and mRNA levels. Therefore,
bottlenecks are believed to occur further upstream in the
translational and/or protein processing machinery.
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